Back to today’s briefing

Story perspectives

79-Year-Old Receives Experimental Obesity Drug; Trump Rumors

6/23/2026

28 4 Full Breakdown

Summary

Story summary

A 79-year-old patient obtained compassionate-use access to Eli Lilly’s experimental obesity drug retatrutide, raising fairness concerns.
NIH clinician Ranganath Muniyappa filed the request that provided the drug.
White House officials refused to confirm the patient’s identity and sent inquiries to HHS.
Social-media users on Bluesky and other sites speculated the patient might be U.S. President Donald Trump because no denial was given.

1 of 1

Story summary

A 79-year-old patient obtained compassionate-use access to Eli Lilly’s experimental obesity drug retatrutide, raising fairness concerns.
NIH clinician Ranganath Muniyappa filed the request that provided the drug.
White House officials refused to confirm the patient’s identity and sent inquiries to HHS.
Social-media users on Bluesky and other sites speculated the patient might be U.S. President Donald Trump because no denial was given.